SRPT vs. CLS
Compare and contrast key facts about Sarepta Therapeutics, Inc. (SRPT) and Celestica Inc. (CLS).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: SRPT or CLS.
Key characteristics
| SRPT | CLS | |
|---|---|---|
| YTD Return | 26.11% | 193.20% |
| 1Y Return | 53.64% | 251.12% |
| 3Y Return (Ann) | 11.45% | 95.79% |
| 5Y Return (Ann) | 4.79% | 61.56% |
| 10Y Return (Ann) | 22.86% | 22.94% |
| Sharpe Ratio | 1.04 | 4.50 |
| Sortino Ratio | 2.18 | 4.15 |
| Omega Ratio | 1.27 | 1.55 |
| Calmar Ratio | 0.91 | 3.43 |
| Martin Ratio | 3.74 | 21.55 |
| Ulcer Index | 13.56% | 11.32% |
| Daily Std Dev | 48.76% | 54.26% |
| Max Drawdown | -98.17% | -96.93% |
| Current Drawdown | -31.96% | 0.00% |
Fundamentals
| SRPT | CLS | |
|---|---|---|
| Market Cap | $11.62B | $9.99B |
| EPS | $1.54 | $3.16 |
| PE Ratio | 78.97 | 27.17 |
| PEG Ratio | 159.25 | 19.42 |
| Total Revenue (TTM) | $1.64B | $9.29B |
| Gross Profit (TTM) | $1.40B | $941.37M |
| EBITDA (TTM) | $70.22M | $724.57M |
Correlation
The correlation between SRPT and CLS is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
SRPT vs. CLS - Performance Comparison
In the year-to-date period, SRPT achieves a 26.11% return, which is significantly lower than CLS's 193.20% return. Both investments have delivered pretty close results over the past 10 years, with SRPT having a 22.86% annualized return and CLS not far ahead at 22.94%. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
SRPT vs. CLS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Sarepta Therapeutics, Inc. (SRPT) and Celestica Inc. (CLS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
SRPT vs. CLS - Dividend Comparison
Neither SRPT nor CLS has paid dividends to shareholders.
Drawdowns
SRPT vs. CLS - Drawdown Comparison
The maximum SRPT drawdown since its inception was -98.17%, roughly equal to the maximum CLS drawdown of -96.93%. Use the drawdown chart below to compare losses from any high point for SRPT and CLS. For additional features, visit the drawdowns tool.
Volatility
SRPT vs. CLS - Volatility Comparison
The current volatility for Sarepta Therapeutics, Inc. (SRPT) is 8.87%, while Celestica Inc. (CLS) has a volatility of 20.46%. This indicates that SRPT experiences smaller price fluctuations and is considered to be less risky than CLS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
SRPT vs. CLS - Financials Comparison
This section allows you to compare key financial metrics between Sarepta Therapeutics, Inc. and Celestica Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities